StockData
Nuvectis Pharma, Inc. logo

Nuvectis Pharma, Inc. (NVCT) stock

NVCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$19.20+0.09 (+0.47%)

Close on Nov 17, 2026Market cap $625.57MP/E –Yield 0.00%

Nuvectis Pharma gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Nuvectis Pharma

Nuvectis Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Nuvectis Pharma figures

See a number that looks wrong?